{"disease":{"id":"immune-responses","name":"immune responses"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03780712","title":"Immune Dysfunction in Newborn Sepsis","phase":"","overall_status":"COMPLETED","enrollment_count":585,"lead_sponsor_name":"BioMérieux","has_results":false},{"nct_id":"NCT06079606","title":"The Effects of Antibiotic Exposure in Early Infancy on Vaccine Responses","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":200,"lead_sponsor_name":"Landspitali University Hospital","has_results":false},{"nct_id":"NCT02231866","title":"Safety, Tolerability, and Immunogenicity of the Ebola Chimpanzee Adenovirus Vector Vaccine (cAd3-EBO), VRC-EBOADC069-00-VP, in Healthy Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":143,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT02408913","title":"VRC 208: Dose, Safety and Immunogenicity of a Recombinant Modified Vaccinia Virus Ankara Ebola Vaccine, VRC-EBOMVA079-00-VP (MVA-EbolaZ), Administered Alone or as a Boost to cAd3-Ebola Vaccines in Healthy Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":140,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":false},{"nct_id":"NCT04329546","title":"Understanding COVID-19","phase":"","overall_status":"COMPLETED","enrollment_count":86,"lead_sponsor_name":"University Hospital, Geneva","has_results":false},{"nct_id":"NCT02956980","title":"Impact of Gender and Pubertal Status on Human Plasmacytoid Dendritic Cells. PLASMACYTOKID","phase":"NA","overall_status":"TERMINATED","enrollment_count":78,"lead_sponsor_name":"University Hospital, Toulouse","has_results":false},{"nct_id":"NCT07527247","title":"Improving Vaccine Protection for Older Adults","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Singapore General Hospital","has_results":false},{"nct_id":"NCT06919796","title":"mRNA Covid-19 Vaccine Immune Response Comparisons Using Different Delivery Routes","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":40,"lead_sponsor_name":"PharmaJet, Inc.","has_results":false},{"nct_id":"NCT03478891","title":"Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-EBOMAB092-00-AB (MAb114), Administered Intravenously to Healthy Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":19,"lead_sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","has_results":true},{"nct_id":"NCT05598073","title":"Racial Differences in Yoga-Induced Responses","phase":"NA","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Texas State University","has_results":false}],"total":10},"guidelines":[],"source":"Drug Landscape verified database"}